Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal progesterone versus aspirin versus no treatment for abnormal uterine artery Doppler in pregnancy
IRCT20101129005272N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of progesterone and aspirin in preeclampsia (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Uterine artery Doppler changes. Started Aug 2018; status: completed.
02
Drugs
progesteroneaspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20101129005272N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101129005272N2.